Daneng Li, GI Medical Oncologist at City of Hope, shared on X/Twitter:
“Out now, the Methods Full article: IMbrave152/SKYSCRAPER-14: a Phase III study of atezolizumab, bevacizumab and tiragolumab in advanced hepatocellular carcinoma. 1st global study with Atezo/bev as comparator. Hopeful for patients with hepatocellular carcinoma.”
Source: Daneng Li/X